Riociguat is an Orally Active sGC Stimulator for Pulmonary Hypertension and Glomerular Disorders Research
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are progressive and debilitating diseases. Briefly, They characterized by gradual obstruction of the pulmonary vasculature, leading to elevated pulmonary artery…